Psychopharmacology And Substance Abuse News

Division 28 American Psychological Association

Volume 39, No 2

DIVISION 28AMERICAN PSYCHOLOGICAL ASSOCIATION

I am proud to proclaim the Division 28 program at the APA convention in New Orleans a success. It was great to see so many of our colleagues attend the con-

ference; we had a very good turn out for most of our scientific sessions. As President of the Division, you feel a responsibility for atten-dance and success of each Division-sponsored session. With APA, attendance at sessions is always relatively low, and with the confer-ence being held in New Orleans following the devastation caused by Katrina, I must admit I had my concerns. I would like to extend my thanks and appreciation to all of you who supported the Division and APA with your attendance and participation. I know the people of New Orleans were appreciative, and many of them went out of their way to thank us for coming.

I’d like to take a moment of your time to thank and acknowledge key contributors to the success of the conference and present some highlights for those of you who could not make it. The most important of these is our Program Chair, Stacey Sigmon from the University of Vermont. Stacey did a magnifi-cent job recruiting for the program, organiz-ing the schedule, coordinating with NIDA and APA, and managing numerous activities at the conference—all this while preparing for, delivering, and caring for her first child. The role of Program Chair is vital to our orga-nization, and has been filled by many of the

scientific leaders of our field; I encour-age you to visit our website to view the list of past Program Chairs.

Big thanks also go to all the symposium chairs for organizing sessions with great breadth and vision. For such a small program, we certainly covered a range of areas that included some of the most pressing issues in our field.

Our award winners who were acknowledged at this year’s convention were as follows. The Brady-Schuster award was accepted by Dr. James Woods, and as usual, Dr. Woods gave an outstanding educational presentation that provided some historical perspective on the field of Behavioral Pharmacology and ended with highlights of exciting new research from his lab. The Young Psychopharmacologist award was presented to Stacey Sigmon from the University of Vermont. The Outstanding Dissertation award was received by William Stoops, a graduate student in Dr. Craig Rush’s laboratory at the University of Kentucky. We also presented Kelly Dunn from the University of Vermont and Shiloh E. Jordan from the University of Missouri Columbia with graduate student awards for Outstanding Poster Presentations. Please extend your congratulations to

From the President’s desk—Alan J. Budney

Continued on page 2

The President’s Desk Continued from page 1

these folks. I’d like to thank Tony Liguori, the Awards Chair for our Division, for his efforts in making these award presentations happen (gathering nominations, reviewing the candidates, ordering award plaques).

Also of note, seven new Division 28 Fellows were approved by the APA last year, and Hendree Jones, Jane Acri, and Douglas Marlowe gave excellent New Fellows’ addresses at the conven-tion. I’d like to quickly acknowledge our Treasurer and new Fellow, Jane Acri. Jane has served the Division as Treasurer for 10 years. In addition to managing the budget, she is respon-sible for assisting with many of the details that go into Division 28 having a successful APA convention. Many thanks Jane.

Although it feels like we just returned from New Orleans, planning for next year’s convention in San Fran-cisco has already begun. I am pleased to announce that Ryan Vandrey from Johns Hopkins has stepped up to the plate to serve as the coming year’s Program Chair. He will be working diligently in collaboration with your President-elect, Suzette Evans, to forge another excellent program conven-tion. Proposals for APA-sponsored workshops are due November 5 and posters and symposium submissions are due on December 1. I hope you all will give serious consideration to partici-pating in next year’s convention.

Next, I would like to announce and thank our new slate of Division Of-ficer candidates for this coming year. Your President-elect ballot will have two candidates: Dr. Craig Rush from the University of Kentucky and Dr. John Roll from the Washington State University. Your Member-at-Large bal-lot will also have two candidates: Dr. David Penetar from McLean Hospi-tal/Harvard Medical School and Dr. Anthony Liguori from Wake Forest

University School of Medicine. Before I end, I’d like to mention a

current issue of import to our Divi-sion. First, APA has created a task force to revisit the curriculum guidelines for psychologists who wish to become qualified for medication prescrip-tion privileges. Our Division was intimately involved in drafting the original curriculum, which focused on high academic standards for the coursework and internships required if we were to ensure high quality train-ing that would produce quality care. Those guidelines are now 10 years old and the concept and practice of psychologist’s prescribing medication has brought new issues to the table. We now have an APA Division focused on pharmacotherapy practice, i.e., Division 55—American Society for Ad-vancement of Psychotherapy. Our rep-resentative to the Task Force is Dr. Ken Sher from the University of Missouri. He will be representing our Division’s continued strong beliefs that a train-ing curriculum with strong academic standards remains warranted to ensure that psychologists who engage in pre-scription are adequately trained. The guidelines for postdoctoral training can be viewed at the following web address: www.apa.org/ed/rx_pmod-curri.pdf. If you are interested in this issue, which has broad implications for training programs and practice in psychology, feel free to contact me or Dr. Sher.

With this, I’ll end by offering the same final comments as I did in my last column. I hope each of you will maintain heightened awareness of the issues that affect our field and thus our professional endeavors. Strive to make time for responding to these issues by providing service to our Divi-sion or taking action through other avenues. Also, please consider contrib-uting each year to the success of our scientific program at the national APA convention. By participating in these

activities, you will be showing appre-ciation for the time and effort devoted by former and current Division leaders that fostered a field of research and application that we can all take pride in. Have to go, grant deadline is ap-proaching!

Sincerely, Alan J. BudneyPresident, Division of

Psychopharmacology and Substance Abuse

2  Psychopharmacology and Substance Abuse News

OBITUARYDr. Frank Holloway, Division 28 president in 2003, died on October 5. Frank received his doctorate from the University of Houston in 1966. His doctoral work was supervised by Dan Sheer, who later founded the neuropsychology program at U of H. Sheer’s students were broadly trained in human and animal neuroanatomy, neurophysiology, and the then fledgling field of behavioral psychopharmacology. Frank spent his entire career in the Department of Psychiatry and Behavioral Sciences at the University of Oklahoma Health Sciences Center, rising through the academic ranks to become a George Lynn Cross Research Professor. For many years, he was the executive director of the Oklahoma Center for Alcohol and Drug Related Studies. Over the years, Frank and his colleagues and students made many important contributions to the field of behavioral pharmacology, most notably in the behavioral pharmacology of alcohol and in understanding discriminative stimulus properties of drugs. Frank had over 130 publications and trained many doctoral and postdoctoral students. In addition to Frank’s service to Division 28 as president, he played a key role in the creation of the APA curriculum guidelines for clinical psychopharmacology training for psychologists interested in obtaining prescription privileges. Frank is survived by his wife, Joan, a neuropsychologist, and three children. He will be missed dearly by all those in his professional and personal communities. The Holloway family has requested that donations be made to the Unitarian Church, 600 NW 13, Oklahoma City, Oklahoma.

division 28 student Poster AwArd winners

Greetings! Today it is my pleasure

to introduce the Division 28 Student

Poster Award winners. Kelly Dunn

and Shiloh Jordan were recognized

for excellence in research at the 2006

APA convention in New Orleans,

Louisiana, and they will each receive

a $100 cash prize. Posters were

judged based on scientific merit and

the presentation of the experiments.

Kelly Dunn is currently a

graduate student in the University

of Vermont’s Experimental Human

Behavioral Pharmacology program.

Her current research focuses on

opioid-dependent populations

and includes characterizing the

continued abuse of Oxycodone in

methadone-maintained patients,

utilizing contingency management

to promote smoking cessation in

methadone-maintained patients, and

developing/implementing a novel

treatment for prescription opioid

abuse. Kelly’s award-winning poster

described a study in which she

sought to determine the frequency

of ongoing Oxycodone abuse in

a clinical sample of methadone-

maintained patients, as well as how

their demographic and drug use

characteristics compare to non-

abusing patients. Twenty-six percent

of the methadone-maintained

patients in Kelly’s sample provided

a Oxycodone-positive urine

sample during the study, and these

patients were more likely to report

a preference for prescription opioids

at intake, to have been in treatment

a shorter duration, and to be

considered less stable in treatment

by clinic staff than participants who

provided no Oxycodone-positive

urine samples. Oxycodone-positive

patients also reported more severe

problems on the Drug and Opiate

composites of the Addiction

Severity Index (ASI). However,

Oxycodone-positive patients also

exhibited several characteristics

that suggest lower drug use severity

than the Oxycodone-negative

group, including more education,

preference toward non-injection

routes of administration, older age

of opioid initiation, and significantly

less severe problems on the alcohol

composites of the ASI. Kelly and

her colleagues concluded that

Oxycodone monitoring should

be incorporated into standard

urinalysis testing protocols during

methadone-maintained treatment,

especially for patients with a history

of prescription opioid abuse.

Shiloh Jordan is a graduate

student in the University of

Missouri-Columbia’s Counseling

Psychology program. One of her

current interests is studying the

role of gender in the differential

experiences of women and men

in substance abuse, including the

development of harm-reduction

interventions that are gender-

specific. In her award-winning

research, Shiloh was interested

in reducing the quantity and

frequency of alcohol consumption

in female college undergraduates.

Additionally, Shiloh and colleagues

sought to increase protective

behaviors (e.g., planning how to

get home before drinking, eating

before drinking) and decrease

image-related behaviors (e.g.,

restricting calories in eating to drink,

increasing physical exercise to burn

calories from drinking). An adapted

or an adapted and abbreviated

version of the ASTP (Alcohol Skills

Training Program) and BASICS

(Brief Alcohol Skills Intervention

for College Students) were used

in three different groups. Women

in the adapted group received a

two-hour co-ed workshop and an

individual follow-up session, women

in the adapted and abbreviated

group received a two-hour all

Psychopharmacology and Substance Abuse News  �

Continued on page 4

Psychopharmacology and Substance Abuse News  �

EDITORIAL POLICY

Psychopharmacology and Substance Abuse News is a thrice-yearly publication of Division 28. It is devoted  to keeping its members informed about the activities of Division 28 and to news and comments concern-ing all aspects of psychopharmacology and substance abuse. Articles, comments, announcements,  and advertisements should be sent to John Roll at johnroll@wsu.edu.  11/06  116064

female workshop, and the control

group consisted of women who

attended an alcohol responsibility

fair. Shiloh’s intervention was

effective in reducing quantity and

frequency of alcohol consumption,

and in both treatment groups, the

extent to which women engaged

in image-related behaviors was

reduced. In addition to focusing

on reducing high-risk drinking,

the results also indicated that the

negative consequences of drinking

can be greatly reduced by targeting

specific drinking-related behaviors in

interventions for women.

Again, congratulations, Kelly

and Shiloh! It is great to see such

exciting research being conducted

by students in our division! As the

outgoing student representative, I

also have the pleasure of introducing

Andrea Vansickle as Division 28’s

new student representative.

Andrea Vansickel received

her bachelor of arts degree in

psychology from the Massachusetts

College of Liberal Arts (MCLA) in

2003. During her time at MCLA,

Andrea conducted research in the

experimental analysis of behavior

under the supervision of Thomas

P. Byrne, Ph.D. She is currently a

graduate student in the Psychology

Department at the University

of Kentucky, working under the

supervision of Craig R. Rush, Ph.D.

Her primary research interests

include identifying potential

pharmacotherapies for stimulant

dependence, and studying ADHD

medications, cigarette smoking, and

gender differences in drug abuse.

As APA Division 28 student

representative, Andrea will reach

out to students involved in

academic programs that focus

on psychopharmacology and

substance abuse. She is committed

to increasing the diversity of the

student affiliate population by

contacting programs at both small

institutions (public or private)

and larger universities across the

country. I am confident that Andrea

will have a very productive year as

student representative! Andrea will

be managing the Division 28 Student

Listserv, adding to the Division

28 Student Web site, maintaining

communication between student

members of the division and the

Executive Committee, and will be

in contact with other APA student

organizations to keep Division 28

students informed of opportunities

within APA. If you have any

comments or questions, or would

like to become more involved in

Division 28 or APA, feel free to

contact Andrea at arvans2@uky.edu.

In my final message as student

representative, I would like to

thank all of the Division 28 student

affiliates. The Executive Committee

also deserves my thanks, as they

have been an incredibly supportive

and fun group to work with. Over

the past year, I have been fortunate

enough to meet or interact with

several students and former

students, and it has been a truly

enjoyable experience. I hope that

each of you will continue to benefit

from involvement in the Division

throughout your career.

Thank you,

Jennifer Perry

CALL For PAPerssPeCiAL issue on the BehAvior AnALysis And treAtment oF drug AddiCtion

Extensive evidence from the

laboratory and the clinic suggests

that drug addiction can be viewed

as operant behavior and effectively

treated through the application of

principles of operant conditioning.

Contingency management inter-

ventions that arrange for the direct

reinforcement of drug abstinence or

of other therapeutically important

target behaviors (e.g., regular use of

drug abuse treatment medications)

are among the most studied type of

operant treatments. Behavior analysts

have contributed to the substantial

and rapidly growing literature on

operant treatments for drug addic-

tion, but the publications of this work

usually appears in medical, clinical

psychology, or drug abuse journals. In

an effort to bring this important work

to the attention of students, faculty,

and researchers in behavior analysis,

the Journal of Applied Behavior Analy-

sis (JABA) will publish a special issue

devoted to the behavior analysis and

treatment of drug addiction. Suit-

able contributions include research

articles, research reports, discussion

articles, review articles, technical arti-

cles, book reviews, or comments from

JABA readers. Submissions should be

relevant to the application of operant

conditioning in the treatment of drug

addiction. Both individual and group

designs are appropriate, although all

empirical reports should include data

on individual participants. Submit

manuscripts to the editor, Patrick C.

Friman, at frimanp@boystown.org

Division 28 Student Poster Award Winners Continued from page 3

(electronic submissions are preferred)

or at Clinical Services and Research,

Youthcare Building, 13603 Flanagan

Blvd., Boys Town, Nebraska 68010,

via the usual process (see JABA

website at seab.envmed.rochester.

edu/jaba/manuscripts.html). Please

include in the cover letter a request to

have the paper considered for publi-

cation in the special issue. The guest

associate editors for this issue will be

Kenneth Silverman, John M. Roll,

and Stephen T. Higgins. For details

about the special issue, please contact

Kenneth Silverman (ksilverm@jhmi.

edu or 410-550-2694) or John Roll

(johnroll@wsu.edu or 509-358-7612).

Submissions for the special issue are

due May 31, 2007.

��th Annual Nebraska Symposium on MotivationTHE MOTIVATIONAL IMPACT OF NICOTINE AND ITS ROLE IN TOBACCO USE

April 12–1�, 2007, at the University of Nebraska-Lincoln

Guest Speakers:

ANTHONY CAGGIULA

University of Pittsburgh

ATHINA MARKOU

University of California-San Diego

KENNETH PERKINS

University of Pittsburgh

JED ROSE

Duke Center for Nicotine & Smoking Cessation Research

REGISTRATION IS FREEPOSTER SUBMISSION DEADLINE: March 9, 2007

www.unl.edu/psypage/symposiumQuestions: Contact Rick Bevins at rbevins1@unl.edu or 402-472-1189

MARINA PICCIOTTO

Yale University School of Medicine

JOHN DANI

Baylor College of Medicine

LINDA DWOSKIN

University of Kentucky

STEPHEN TIFFANY

University of Utah School of Medicine

� Psychopharmacology and Substance Abuse News

� Psychopharmacology and Substance Abuse News Psychopharmacology and Substance Abuse News  7

In 2007, Experimental and

Clinical Psychopharmacology will

increase the number of issues pub-

lished from 4 to 6 issues each year

Experimental and Clinical

Psychopharmacology publishes

advances in translational and inter-

disciplinary research on psychophar-

macology and drug abuse. The scope

of research in these areas continues

to expand, and to benefit from col-

laborations across a broad range of

disciplines, including behavioral

science, brain imaging, genetics,

neuroendocrinology, neuroscience,

and pharmacology. One goal of the

journal is to encourage increased at-

tention to biologic factors that may

influence both the pharmacody-

namic and pharmacokinetic effects

of drugs.

Nancy K. Mello, Ph.D., Editor

To submit a paper go to:

www.apa.org/journals/pha/submis-

sion.html

For more information, go to:

www.apa.org/journals/pha

Faculty Position, Department of Psychology, Austin College,

Sherman, TexasThe Department of Psychology invites ap-

plications for a tenure-track assistant professor of psychology position beginning August 2007. Austin College is a selective national liberal arts college with an enrollment of 1300 undergradu-ates. Preference given to candidates having the doctorate in developmental psychology, area of specialization open. The successful candidate can expect to teach introductory psychology, re-search methods or statistics, lifespan psychology (an upper-level course required for the major) and courses in areas of expertise. The depart-ment supports a range of collaborative research and internship opportunities for undergraduates. Strong commitment to teaching, participation in college-wide interdisciplinary program, and Ph.D. required. Send letters of application, CV, official graduate transcripts, three letters of refer-ence, and statement of teaching philosophy to Dr. Michael Imhoff, VPAA, Austin College, 900 North Grand Avenue, Sherman, TX 75090-4400. For fullest consideration, all materials should be received by November 1, 2006. AA/EOE. For more information about the position and Austin College, visit www.austincollege.edu/Jobs.asp?828.

Postdoctoral Research Fellowships, Johns Hopkins University,

Baltimore, MarylandPostdoctoral research fellowships in

stimulating, productive program with excellent resources. Prepare as independent investigator.

HumAN LAbORATORy—behavioral & clinical pharmacology of abused drugs (abuse liability, self-administration, cognitive function, neuroimaging); anti-drug-abuse medications development. Opioids, cocaine, anxiolytics, alcohol, caffeine, nicotine, hallucinogens/psy-chedelics, MDMA, club drugs.

CLINICAL TRIALS—testing medications, verbal & behavioral therapies (esp. incentive/contingency/motivation-based), and com-binations; psychiatric comorbidity research; addiction & pregnancy/women. Opioid, cocaine, tobacco, mixed/other dependencies.

Eligibility: U.S. citizen, permanent resident. A broad range of backgrounds are ap-propriate from clinical/counseling to experimen-tal/neuroscience.

NIH stipend levels: $37K - 51K+. Start Date: Flexible.Faculty: George Bigelow, Roland Griffiths,

Maxine Stitzer, Eric Strain, Ken Silverman, Rob-ert Brooner, Miriam Mintzer, Una McCann, et al.

Contact: George Bigelow; BPRU, Behav-ioral Biology Research Center, 5510 Nathan Shock Drive, Johns Hopkins Bayview Campus, Baltimore, Maryland 21224-6823, 410-550-0035, bigelow@jhmi.edu, www.bpru.org

Two Faculty Positions, Department of Medical Humanities and Social Sciences, Florida State University College of Medicine, TallahasseeTwo junior tenure-track faculty positions at

new medical school committed to biopsychoso-cial model and serving rural, underserved, mi-nority, and elderly populations. Research interest and expertise in any of the following areas is particularly welcome: patient-provider commu-nication, medical education, minority health, substance abuse, or behavioral medicine. Send c.v., statement of research, teaching, and profes-sional interests, and names of three references to: Suzanne Bennett Johnson, Ph.D., Dept. of Medical Humanities and Social Sciences, Florida State University College of Medicine, Tallahas-see, FL 32306-4300, 850-644-8462, Suzanne.johnson@med.fsu.edu. Review of applicants will begin October 1 and continue until the position is filled.

Postdoctoral Program, Drug Abuse Treatment and Services Research,

University of California, San Francisco (UCSF)

Traineeships in drug abuse treatment and services research are available in the UCSF Department of Psychiatry in a large, active, multidisciplinary research environment that is supported by multiple research projects and center grants. Scholars work with a preceptor to design and implement studies. The focus is on treatment and services research in drug dependence, including tobacco dependence. Scholars also select an area of focus for inde-pendent research. Current research interests of faculty include trials of efficacy and effectiveness of psychosocial and pharmacologic treatment of drug abuse, including tobacco dependence; innovative methodology including internet based studies; treatment of complex patients in non-traditional settings; research on treatment tailored for HIV-positive drug abusers and drug abusers with psychiatric and medical disorders; research on provision of services to drug abusing populations; human genetics and nicotine; in-strument development in drug abuse; and diag-nostic techniques. Successful applicants include psychologists with strong scientific backgrounds; scholars with backgrounds in epidemiology, methodology, nursing, psychiatry, health policy, pharmacology, public health, and social work; and basic scientists who wish to learn the skills needed to translate their work to treatment and clinical issues. Stipends are funded by the National Institute on Drug Abuse. Preceptors are encouraged to supplement stipends from non-NIH sources. A priority of the department is the training of women and minorities for academic research careers. The priority application filing period closes January 15, 2007.

Please see our website at www.ucsf.edu/sftrc or contact Lorel Hiramoto at lhiramoto@lppi.ucsf.edu or 415-476-7673 for a program brochure. Sharon Hall, Ph.D., Kevin Delucchi, Ph.D., Joseph Guydish, Ph.D., Barbara Havassy, Ph.D., James Sorensen, Ph.D., and Connie Weis-ner, Dr.P.H. are Co-Directors.

Postdoctoral Training Program in Drug Abuse Treatment and Services ResearchUniversity of California, San Francisco401 Parnassus Avenue, UCSF Box 0984-TRCSan Francisco, CA 94143-0984www.ucsf.edu/sftrc

Postdoctoral Position, University of Pittsburgh Medical Center,

Pennsylvania

A postdoctoral position in the behavioral pharmacology of nicotine in humans may be available in the laboratory of Dr. Kenneth A. Perkins at the University of Pittsburgh. This po-sition is funded through NHLBI. Ongoing NIDA-supported projects focus on: 1) environmental modulation of nicotine responses and tobacco self-administration, 2) individual differences associated with sensitivity to nicotine or smok-ing, including gender, genetic, and personality factors, and 3) development of short-term proce-dures for evaluating the efficacy of medications for smoking cessation.

Interested candidates should send a C.V. and letter of interest to Dr. Perkins at the following address:

Kenneth A. Perkins, Ph.D.Department of PsychiatryUniversity of Pittsburgh Medical Center3811 O’Hara StreetPittsburgh, PA 15213

Voice: 412-246-5395Fax: 412-246-5390perkinska@upmc.edumyprofile.cos.com/perkinsk31

Postdoctoral Associate Position, Yale University School of Medicine, New

Haven, ConnecticutDepartment of Psychiatry at Yale Univer-

sity School of Medicine, Division of Substance Abuse/Law and Psychiatry seeks a motivated, licensed eligible psychologist to work on study protocols that aim to treat substance abusing clients with criminal justice involvement. The protocols involve assessing the link between sub-stance use, domestic violence, and criminal be-havior as well as developing behavioral therapies to treat men with co-occurring substance abuse and intimate partner violence. Moreover, this position seeks an individual who has statistical expertise, interested in manuscript preparation, as well as providing motivational enhancement therapy and cognitive behavioral therapy to substance abusing clients. Salary and benefits are competitive. Position available immediately. Send letter of interest, curriculum vitae, and three letters of reference to: Caroline Easton, Ph.D., Department of Psychiatry, Yale University School of Medicine, ASAP/SATU, Box 18, 1 Long Wharf, New Haven, CT 06511 or e-mail to caroline.easton@yale.edu and call with any ques-tions or comments: 203-974-5730.

Employer: Yale University, Department of Psychiatry, Division of Substance Abuse

Contact Information: Caroline Easton, Ph.D.

E-mail Address: Caroline.Easton@Yale.Edu

ELECTED OFFICERS: President Alan Budney Past President James Zacny President-Elect Suzette Evans Council Representative John Grabowski Members-at-Large Craig Rush Nancy Petry Kimberly Kirby

APPOINTED OFFICERS: Secretary Drake Morgan Treasurer Jane B. Acri Newsletter Editor John Roll Divisional Awards Anthony Liguori Membership Joshua Lile, jalile2@uky.edu New Fellows Stephen Heishman Convention Program Chair 2005 Diana Walker 2006 Stacey Sigmon

INFORMATION OFFICERS: Archivist Richard Foltin Electronic Information Ronald W. Wood COMMITTEE CHAIRS: Continuing Education M. Marlyne Kilbey

APPOINTED LIAISONS/MONITORS: Board of Scientific Affairs Marilyn Carroll Ronald Wood Board of Educational Affairs M. Marlyne Kilbey Liaison to Division 50 Linda Sobell Women’s Network Representative Nancy Piotrowski International Relations Committee Mark Fillmore Liaison to CARE James Rowlett Student Representative Jennifer Perry Liaison to Scientific Directorate Conrad Wong Liaison to Division 55 Mark Fillmore

division 28 exeCutive Committee

Visit our new Web site:

www.apa.org/divisions/div28

John M. Roll, Ph.D.DirectorWashington Institute for Mental Illness Research and TrainingWashington State University SpokanePO Box 1495Spokane, WA 99210-1495